Here's our monthly update on our 32 stocks, including 2 more names to buy

cnbc.com · 2026-10-15

Jim Cramer identified two of his favorite stocks to buy and the names he's not willing to touch just yet.

TickrTrends take: Johnson & Johnson is among 32 stocks included in a monthly portfolio update, though the specific recommendation for JNJ within that update was not detailed. TickrTrends currently rates JNJ as overvalued, suggesting that valuation-focused investors may want to monitor whether upcoming fundamental developments in the Healthcare sector could justify or further challenge this assessment. Given this overvalued designation, readers tracking JNJ should pay particular attention to whether the company's earnings growth or strategic announcements might narrow the gap between current market price and intrinsic value.

Read the full story at cnbc.com →